Monitoring intraocular pressure with EYEMATE


Increased intraocular pressure makes glaucoma more likely. Often, the disease is not recognized in time. The EYEMATE sensor system developed by Fraunhofer IMS and Implandata Ophthalmic Products GmbH makes continuous monitoring of intraocular pressure easier, allowing for optimum treatment.

© MEV Verlag

EYEMATE allows doctors and patients to continuously monitor the intraocular pressure.

© Fraunhofer IMS

Encapsulated sensor implant for measuring intraocular pressure.

Our eyes are home to a constant exchange of aqueous humor – new humor is produced and old humor is expelled. If, however, the quantity of new aqueous humor is greater than the quantity of humor being expelled, the intraocular pressure rises, which may result in irreversible damage, even death of the optic nerve. This condition is referred to as glaucoma.

Until now, only physicians have been able to measure intraocular pressure. The data is often collected at irregular intervals, and values from throughout the day are not collected. Medical or surgical treatments can thus often only be started once irreversible damage has occurred. Furthermore, a lack of data increases the risk of incorrect treatment decisions being made. 

At-home measuring system

The EYEMATE handheld reader allows patients to measure these parameters themselves within a few seconds. The digitalized data is displayed straight away and changes across time can be viewed using a mobile app. A cloud connection can also allow the doctor to access the data and thus to start or optimize the right treatment in good time. 

Regular check-ups

The handy format and user friendliness will encourage patients to use the device as often as possible, creating a useful store of data. The system has already proven itself in clinical studies; the CE approval process has been completed.